INTEGRATED CANCER CARE · VANCOUVER, BC, CANADA
Monday–Friday 9–5   |   604-428-1991
Research library

Effect of preoperative fever-range whole-body hyperthermia on immunological markers in patients undergoing colorectal cancer surgery

Br J Anaesth. 2012 Nov;109(5):754-61. doi: 10.1093/bja/aes248. Epub 2012 Jul 31. Effect of preoperative fever-range whole-body hyperthermia on immunological markers in patients undergoing colorectal cancer …

Research archive · This publication is preserved from the LEMMO Cancer Care library. Findings are specific to the study design and population and may not reflect current clinical practice.

Br J Anaesth. 2012 Nov;109(5):754-61. doi: 10.1093/bja/aes248. Epub 2012 Jul 31.

Effect of preoperative fever-range whole-body hyperthermia on immunological markers in patients undergoing colorectal cancer surgery.

Sulyok I, Fleischmann E, Stift A, Roth G, Lebherz-Eichinger D, Kasper D, Spittler A, Kimberger O.

Source

Division of General Anaesthesia and Intensive Care, Department of Anaesthesiology, General Intensive Care and Pain Control, Medical University of Vienna, Vienna, Austria.

Abstract

BACKGROUND:

Previous studies have demonstrated beneficial immunological effects of fever-range whole-body hyperthermia (FR-WBH) as an adjunct to non-surgical cancer therapy. We conducted a study of preoperative FR-WBH in patients undergoing colorectal cancer surgery to evaluate perioperative,hyperthermia-induced immunomodulation.

METHODS:

The trial was conducted as a subject-blinded, controlled, randomized study. Subjects in the FR-WBH group (n=9) were treated with FR-WBH before operation under propofol sedation; the target core temperature was 39 (0.5)°C with 1 h warming and 2 h plateau phase. Subjects in the control group (n=9) were treated with propofol sedation only. Blood samples were acquired before and after treatment, after operation, and 24, 48 h, and 5 days after the end of surgery. The following parameters were measured: lipopolysaccharide (LPS)-induced tumour necrosis factor (TNF)-α, procalcitonin (PCT), interleukin (IL)-6/10, heat shock proteins (HSPs) 60, 70, and 90, human leucocyte antigen-DR (HLA-DR), and LPS-binding protein (LBP).

RESULTS:

HSPs were increased in the FR-WBH group after treatment [HSP60, 48 h postop: 143 (41)% vs 89 (42)%, P=0.04; HSP90, postop: 111 (33)% vs 64 (31)%, P=0.04; HSP70: P=0.40; FR-WBH vs control, P-values for area under the level/time curve]. TNF-α levels were elevated after surgery in the control group and remained near baseline in the FR-WBH group [24 h postop: 73 (68)% vs 151 (72)%, P=0.04]. PCT increased in both groups 24 h after surgery; in the control group, this increase was significantly higher (P=0.02). There were no significant differences for IL, HLA-DR, or LBP.

CONCLUSIONS:

The immune system to react to surgical stress, as measured by a panel of laboratory indicators, might be improved by preoperative FR-WBH.

Comment in

LEMMO Integrated Cancer Care
We’re here to help

A conversation can
be a beginning.

Have a question about our care or becoming a patient? Our team can explain your first visit and help you take the next step.

Let’s talk about your next step

Send us a message

For appointments and general enquiries. Leave us a message and our team will be in touch.

Call our team
604-428-1991
Email us
info@lemmo.com
Visit our clinic
Suite 205, 3900 Hastings Street
Burnaby, BC V5C 6C1
Office hours
Monday–Friday
9:00 am–5:00 pm
By appointment

Find us in Burnaby

Directions